Please login to the form below

Not currently logged in
Email:
Password:

Cluster headaches

This page shows the latest Cluster headaches news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly scores positive phase 3 results for Emgality in treatment resistant migraine

Eli Lilly scores positive phase 3 results for Emgality in treatment resistant migraine

Since then, the drug also claimed the first FDA approval in the class for cluster headaches earlier this year.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics